ARCOFELIZ
LIVE

Serial Number

79279254

Owner

Nagase ChemteX Corporation

Attorney

Ryan M. Kaiser

Filing Date

Nov 7, 2019

Add to watchlist:

No watchlists yet
View on USPTO

ARCOFELIZ Trademark

Serial Number: 79279254 • Registration: 6604342

ARCOFELIZ is a trademark filed by Nagase ChemteX Corporation on November 7, 2019. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Nagase ChemteX Corporation (6 trademarks)

1-1-17, Shinmachi,
Nishi-ku, Osaka-shi, O 5508668 , JP

Entity Type: 03

Trademark Details

Filing Date

November 7, 2019

Registration Date

January 4, 2022

Published for Opposition

July 20, 2021

Goods & Services

Gelatine for medical purposes, namely, gelatine for use as a hemostatic, gelatine for use as an adhesive for binding wounds, gelatine for use as anti-adhesion gels for wound drainage devices, gelatine for use as a lubricant for artificial blood vessels and catheters, and gelatine for use as an adhesive to biotissue for artificial blood vessels and catheters; collagen for medical purposes; collagen peptides for medical purposes; in vitro diagnostic reagents for medical and veterinary use; microorganism culture mediums for regenerative medicine purposes; pharmaceutical preparations, namely, hemostatics, medical adhesives for binding wounds, and anti-adhesion gels for use with wound drainage devices for surgical treatment; pharmaceutical preparations, namely, biological cell culture mediums for regenerative medicine purposes and biological preparations for use as a hemostatic, for use as an adhesive for binding wounds, for use as anti-adhesion gels for wound drainage devices, for use as a medical lubricant for artificial blood vessels and catheters, and for use as a medical adhesive to biotissue for artificial blood vessels and catheters; dental materials, namely, dental ceramics, dental cement; lactose for pharmaceutical purposes; lacteal flour for babies; cotton swabs for medical use

Reagents for research purposes for pharmaceuticals, regenerative medicine, and implantable medical apparatus and instruments, other than for medical or veterinary purposes; biological cell culture mediums for scientific and research purposes for pharmaceuticals, regenerative medicine, and implantable medical apparatus and instruments; biological cell culture mediums used for regenerative medicine or for use in the manufacture of pharmaceuticals; industrial chemicals for research purposes for pharmaceuticals, regenerative medicine, and implantable medical apparatus and instruments; chemicals for use in the manufacture of biological cell culture media for pharmaceuticals and regenerative medicine; chemicals for use in the manufacture of pharmaceuticals and implantable medical apparatus and instruments; plant growth regulating preparations; higher fatty acids for industrial use; artificial sweeteners; gelatine for use in the manufacture of cosmetics; collagen peptides for use in the manufacture of cosmetics; chemical compositions for developing photographs

Medical apparatus and instruments, namely, medical endoscopes, catheters, medical ultrasound apparatus, medical devices for nonsurgical cosmetic treatments, medical devices for closing wounds, hemostatic suture instruments, medical and surgical instruments and apparatus for preventing the formation of adhesions after surgical procedures, artificial blood vessels, artificial joints; pacifiers for babies; ice bag pillows for medical purposes; triangular bandages for anatomical joints; supportive bandages; surgical catguts; feeding cups for medical purposes; dropping pipettes for medical purposes; feeding bottle teats; medical ice bags; medical ice bag holders, namely, medical apparatus in the nature of dispensers for plastic ice bags; baby bottles; nursing bottles; finger guards for medical purposes; non-chemical contraceptives, namely, contraceptive apparatus; artificial tympanic membranes; prosthetics or fillings materials, namely, artificial materials for use in the replacement of bones and cartilage; bracelets for medical purposes

Filing History

NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
Apr 29, 2025 NURC
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Jul 12, 2024 ERRR
AMENDMENT UNDER SECTION 7 - PROCESSED
Jul 8, 2024 A7OK
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jul 3, 2024 APRE
TEAS SECTION 7 REQUEST RECEIVED
Nov 28, 2023 ES7R
NEW REPRESENTATIVE AT IB RECEIVED
May 20, 2023 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 12, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jun 16, 2022 FICS
FINAL DISPOSITION PROCESSED
Jun 16, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 4, 2022 FICR
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Mar 17, 2022 CORN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Mar 9, 2022 LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Feb 2, 2022 LIMN
CORRECTION TRANSACTION RECEIVED FROM IB
Jan 21, 2022 CRCV
LIMITATION OF GOODS RECEIVED FROM IB
Jan 21, 2022 LIMG
REGISTERED-PRINCIPAL REGISTER
Jan 4, 2022 R.PR
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Nov 28, 2021 ETOP
LIMITATION OF GOODS RECEIVED FROM IB
Nov 21, 2021 LIMG
EXTENSION OF TIME TO OPPOSE RECEIVED
Aug 18, 2021 ETOF
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Aug 7, 2021 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 21, 2021 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jul 21, 2021 OPNR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 20, 2021 NPUB
PUBLISHED FOR OPPOSITION
Jul 20, 2021 PUBO
NOTIFICATION PROCESSED BY IB
Jul 18, 2021 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 30, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jun 30, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 30, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 17, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 17, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 17, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 17, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 17, 2021 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
Dec 22, 2020 GNFN
FINAL REFUSAL E-MAILED
Dec 22, 2020 GNFR
FINAL REFUSAL WRITTEN
Dec 22, 2020 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 1, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 1, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 1, 2020 TROA
NON-FINAL ACTION MAILED
Jun 16, 2020 CNRT
NON-FINAL ACTION WRITTEN
Jun 15, 2020 CNRT
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
Jun 15, 2020 LIME
LIMITATION OF GOODS RECEIVED FROM IB
May 8, 2020 LIMG
REFUSAL PROCESSED BY IB
Apr 10, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 24, 2020 RFCS
REFUSAL PROCESSED BY MPU
Mar 24, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 4, 2020 RFCR
NON-FINAL ACTION WRITTEN
Mar 3, 2020 CNRT
APPLICATION FILING RECEIPT MAILED
Feb 29, 2020 MAFR
ASSIGNED TO EXAMINER
Feb 25, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 25, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 20, 2020 REPR